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Background: Cardiogenic shock remains one of the major causes of death in patients with AMI. This study investigated whether mortality of 
cardiogenic shock complicating AMI was reduced along with the therapeutic advances in the recent years.
Methods: Cardiogenic shock was defined as Killip IV class. Among 6,995 consecutive AMI patients registered to the Osaka Acute Coronary 
Insufficiency Study (OACIS) between 1998 and 2006, a total of 428 patients (6.1%) had cardiogenic shock on admission, and were enrolled in the 
study (mean age 70+11 y.o., male 70%). Patient characteristics, treatment, and outcomes were compared among the three periods according to the 
admission year (1998-2000, n=135, 2001-2003, n=157, and 2004-2006, n=136).
Results: The treatment for cardiogenic shock complicating AMI changed dramatically, whereas admission baseline characteristics did not. The rates 
of coronary angiography and subsequent percutaneous coronary intervention (PCI) slightly increased from 1998-2000, 2001-2003, to 2004-2006 
(from 87%, 89%, to 94%; p=0.11, and from 76%, 78%, to 85%; p=0.17, respectively), along with an increase in coronary stenting and intracoronary 
thrombectomy (47%, 83%, and 91%; p<0.01, and 3%, 26%, and 38%; p<0.01, respectively). Utilization rates of cardiac assist devices were not 
changed during the periods (65%, 65%, and 65%; p=1.00, for intra-aortic balloon pumping, and 20%, 24%, and 26%, p=0.51, for percutaneous 
cardio-pulmonary support). In-hospital mortality decreased from 1998-2000 to 2001-2003, and 2004-2006 (54%, 50%, and 31%; p<0.01). Three-
year mortality in those who discharged alive tended to decrease (21%, 18%, and 8%, p=0.12). Reperfusion therapy was an independent predictor 
both for survival discharge (HR 2.64, p=0.031), and subsequent three-year survival (HR 7.48, p=0.002).
Conclusions: Clinical outcomes in patients with cardiogenic shock complicating AMI became getting better, along with progress of coronary 
reperfusion.
